About BIOAEGIS THERAPEUTICS INC
BioAegis Therapeutics is a clinical-stage private company developing therapies for inflammatory diseases based on plasma gelsolin (pGSN), a natural immune regulator. The company focuses on restoring immune balance without immunosuppression and has a strong IP portfolio.
Development of therapies for inflammatory diseasesUtilization of plasma gelsolin (pGSN) as a natural immune regulatorCreation of recombinant human plasma gelsolin (rhu-pGSN) for non-immunosuppressive treatmentExtensive IP portfolio with over 40 global patentsCollaborations with leading research institutions and industry partners
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $749K | |
| BIOAEGIS: PLASMA GELSOLIN (PGSN), AN ABUNDANT, CIRCULATING PROTEIN MODULATES INFLAMMATION WHILE ALSO ENHANCIN | Department of Health and Human Services | $20.0M |
Is this your company?
Claim BIOAEGIS THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim BIOAEGIS THERAPEUTICS INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.